- Home
- KROS vs EE Comparison
KROS vs EE Comparison
Compare KROS & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- EE
- Stock Information
- Founded
- KROS 2015
- EE 2003
- Country
- KROS United States
- EE United States
- Employees
- KROS N/A
- EE N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- KROS Health Care
- EE Utilities
- Exchange
- KROS Nasdaq
- EE Nasdaq
- Market Cap
- KROS 558.9M
- EE 914.5M
- IPO Year
- KROS 2020
- EE 2022
- Fundamental
- Price
- KROS $14.68
- EE $26.77
- Analyst Decision
- KROS Buy
- EE Hold
- Analyst Count
- KROS 13
- EE 7
- Target Price
- KROS $20.63
- EE $32.29
- AVG Volume (30 Days)
- KROS 487.4K
- EE 476.1K
- Earning Date
- KROS 08-06-2025
- EE 08-06-2025
- Dividend Yield
- KROS N/A
- EE 0.89%
- EPS Growth
- KROS N/A
- EE 37.63
- EPS
- KROS 0.11
- EE 1.53
- Revenue
- KROS $214,713,000.00
- EE $966,414,000.00
- Revenue This Year
- KROS $5,006.76
- EE $36.94
- Revenue Next Year
- KROS N/A
- EE $18.61
- P/E Ratio
- KROS $132.53
- EE $17.73
- Revenue Growth
- KROS 91657.70
- EE N/A
- 52 Week Low
- KROS $9.12
- EE $17.54
- 52 Week High
- KROS $72.37
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- EE 31.93
- Support Level
- KROS $13.26
- EE $26.62
- Resistance Level
- KROS $14.68
- EE $29.27
- Average True Range (ATR)
- KROS 0.41
- EE 0.84
- MACD
- KROS 0.12
- EE -0.30
- Stochastic Oscillator
- KROS 89.35
- EE 4.02
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.